Literature DB >> 7838910

Influence of naloxone upon motor activity induced by psychomotor stimulant drugs.

D N Jones1, S G Holtzman.   

Abstract

Naloxone, an opioid receptor antagonist, attenuates a wide range of behavioral effects of d-amphetamine, such as the stimulation of motor activity. To investigate the pharmacological selectivity of the naloxone/amphetamine interaction, we assessed the effects of naloxone (5.0 mg/kg SC) upon motor activity induced in rats by a range of psychomotor stimulant drugs with a mechanism of action either similar to or different from that of d-amphetamine. Each of the drugs tested caused dose-dependent increases in both gross and fine activity. Naloxone attenuated the gross but not the fine activity response to d- and l-amphetamine, but had no influence upon the other catecholamine-releasing drugs, methamphetamine and phendimetrazine. In contrast, naloxone increased the gross but not the fine activity response to the catecholamine uptake inhibitors cocaine and mazindol, but had no effects upon the motor response to methylphenidate. The responses to other stimulant drugs (apomorphine, caffeine, scopolamine) were unaffected by naloxone pretreatment. The present findings extend the range of conditions under which naloxone and, by inference, endogenous opioid systems, modulate the behavioral response to psychomotor stimulants. However, the differential effects of naloxone upon the motor response to individual stimulant drugs support previous suggestions of fundamental differences in mechanisms of action among these compounds.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7838910     DOI: 10.1007/bf02244839

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  77 in total

1.  Modulation of the discriminative stimulus effects of cocaine by mu and kappa opioids.

Authors:  R D Spealman; J Bergman
Journal:  J Pharmacol Exp Ther       Date:  1992-05       Impact factor: 4.030

2.  Behavioral effects of separate and combined administration of naloxone and d-amphetamine.

Authors:  S G Holtzman
Journal:  J Pharmacol Exp Ther       Date:  1974-04       Impact factor: 4.030

3.  The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine.

Authors:  U V Berger; X F Gu; E C Azmitia
Journal:  Eur J Pharmacol       Date:  1992-05-14       Impact factor: 4.432

4.  Effects of naloxone infusion upon spontaneous and amphetamine-induced activity.

Authors:  D N Jones; S G Holtzman
Journal:  Eur J Pharmacol       Date:  1992-10-06       Impact factor: 4.432

5.  The role of GABA receptors in the control of nigrostriatal dopaminergic neurons: dual-probe microdialysis study in awake rats.

Authors:  M Santiago; B H Westerink
Journal:  Eur J Pharmacol       Date:  1992-08-25       Impact factor: 4.432

6.  Effects of naloxone and diprenorphine on amphetamine-stimulated behavior in guinea pigs and rats.

Authors:  J S Andrews; S G Holtzman
Journal:  Neuropharmacology       Date:  1987-08       Impact factor: 5.250

7.  Withdrawal of repeated cocaine decreases autoradiographic [3H]mazindol-labelling of dopamine transporter in rat nucleus accumbens.

Authors:  L G Sharpe; N S Pilotte; W M Mitchell; E B De Souza
Journal:  Eur J Pharmacol       Date:  1991-10-02       Impact factor: 4.432

8.  Cocaine place preference is blocked by the delta-opioid receptor antagonist, naltrindole.

Authors:  K Menkens; E J Bilsky; K D Wild; P S Portoghese; L D Reid; F Porreca
Journal:  Eur J Pharmacol       Date:  1992-08-25       Impact factor: 4.432

9.  Naloxone attenuation of the effect of cocaine on rewarding brain stimulation.

Authors:  G T Bain; C Kornetsky
Journal:  Life Sci       Date:  1987-03-16       Impact factor: 5.037

10.  Opioid mediation of cocaine-induced hyperactivity and reinforcement.

Authors:  A A Houdi; M T Bardo; G R Van Loon
Journal:  Brain Res       Date:  1989-09-11       Impact factor: 3.252

View more
  7 in total

Review 1.  The sigma-1 receptor as a regulator of dopamine neurotransmission: A potential therapeutic target for methamphetamine addiction.

Authors:  Danielle O Sambo; Joseph J Lebowitz; Habibeh Khoshbouei
Journal:  Pharmacol Ther       Date:  2018-01-31       Impact factor: 12.310

2.  Opioid sensitivity in mice selectively bred to consume or not consume methamphetamine.

Authors:  Emily C Eastwood; Tamara J Phillips
Journal:  Addict Biol       Date:  2012-11-12       Impact factor: 4.280

3.  Morphine intake and the effects of naltrexone and buprenorphine on the acquisition of methamphetamine intake.

Authors:  E C Eastwood; T J Phillips
Journal:  Genes Brain Behav       Date:  2013-11-18       Impact factor: 3.449

4.  Prevention of cocaine-induced hyperactivity by a naloxone isomer with no opiate antagonist activity.

Authors:  N Chatterjie; G J Alexander; J A Sechzer; K W Lieberman
Journal:  Neurochem Res       Date:  1996-06       Impact factor: 3.996

Review 5.  Roles of micro-opioid receptors in GABAergic synaptic transmission in the striosome and matrix compartments of the striatum.

Authors:  Masami Miura; Masao Masuda; Toshihiko Aosaki
Journal:  Mol Neurobiol       Date:  2008-05-13       Impact factor: 5.590

6.  Safety and tolerability of intranasal cocaine during phendimetrazine maintenance.

Authors:  William W Stoops; Justin C Strickland; Lon R Hays; Abner O Rayapati; Joshua A Lile; Craig R Rush
Journal:  Psychopharmacology (Berl)       Date:  2016-03-01       Impact factor: 4.530

7.  Abuse Potential of Oral Phendimetrazine in Cocaine-dependent Individuals: Implications for Agonist-like Replacement Therapy.

Authors:  B Levi Bolin; William W Stoops; Jeremy P Sites; Craig R Rush
Journal:  J Addict Med       Date:  2016 May-Jun       Impact factor: 3.702

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.